Agent that triggers immune response in plants is uncoveredOctober 05, 2007Although plants lack humans' T cells and other immune-function cells to signal and fight infection, scientists have known for more than 100 years that plants still somehow signal that they have been attacked in order to trigger a plantwide resistance. Now, researchers at the Boyce Thompson Institute for Plant Research (BTI) on the Cornell campus have identified the elusive signal in the process: methyl salicylate, an aspirin-like compound that alerts a plant's immune system to shift into high gear. This phenomenon is called systemic acquired resistance and is known to require movement of a signal from the site of infection to uninfected parts of the plant. The findings are published in the Oct. 5 issue of Science.
"By finally identifying a signal that moves from an infection site to activate defenses throughout the plant, as well as the enzymes that regulate the level of this signal, we may be in a position to alter the signal in a way that enhances a plant's ability to defend itself," said BTI senior scientist Daniel F. Klessig, an adjunct professor in plant pathology at Cornell, who conducted the work with Sang-Wook Park and other BTI colleagues. Their approach, using gene technology to enhance plant immunity, could have wide consequences, boosting crop production and reducing pesticide use. Methyl salicylate is a modified form of salicylic acid (SA), which has been used for centuries to relieve fever, pain and inflammation, first through the use of willow bark and, since 1889, with aspirin, still the most widely used drug worldwide. In the 1990s, Klessig's research group reported that SA and nitric oxide are two critical defense-signaling molecules in plants, as well as playing important roles in human health. Then, in 2003 and 2005, the group reported in the Proceedings of the National Academy of Sciences that an enzyme, salicylic acid-binding protein 2 (SABP2), is required for systemic acquired resistance and converts methyl salicylate (which is biologically inactive as it fails to induce immune responses) into SA, which is biologically active. After plants are attacked by a pathogen, the researchers had previously found, they produce SA at the infection site to activate their defenses. Some of the SA is converted into methyl salicylate, which can be converted back into SA by SABP2. Using plants in which SABP2 function was either normal, turned off or mutated in the infected leaves or the upper, uninfected leaves, Klessig's group showed that SABP2 must be active in the upper, uninfected leaves for systemic acquired resistance to develop properly. By contrast, SABP2 must be inactivated in the infected leaves by binding to SA. "This inactivation allows methyl salicylate to build up," explained Klessig. "It then flows through the phloem (or food-conducting "tubes") to the uninfected tissue, where SABP2 converts it back into active SA, which can now turn on the plant's defenses." Klessig said that it is unclear why plants send this hormone to uninfected tissue in an inactive form, which then must be activated by removal of the methyl group. "This research also provides insight into how a hormone like SA can actively regulate its own structure -- and thereby determine its own activity -- by controlling the responsible enzyme," noted Park, the lead author of the paper. Cornell University News Service Science News and Science Current Events Tag Cloud This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size. Nanoscale Nuclear Medicine Heart Failure Botulinum Neurotoxin Sperm Hippocampus Chromatin Mammography Fear Eye Movement Cervical Cancer Immune Cells Obsessive-compulsive Disorder Public Health Tomato Stents Drug Abuse Epithelial Cells Cognitive Impairment Mosquitoes Allergic Reaction Resveratrol Silicon Elephants Stroke Damage
See More: Science News Tags | |||||||||||||||||||||
|
Related Immune Response Current Events and Immune Response News Articles UCLA collaboration identifies immune system link to schizophrenia Schizophrenia is a devastating mental disease, thought to be caused by the interaction of both genetic and environmental factors. Harvard scientists solve mystery about why HIV patients are more susceptible to TB infection A team of Harvard scientists has taken an important first step toward the development of new treatments to help people with HIV battle Mycobacterium tuberculosis (TB) infection. Study identifies biomarker that safely monitors tumor response to new brain cancer treatment A specific biomarker, a protein released by dying tumor cells, has been identified as an effective tool in an animal model to gauge the response to a novel gene therapy treatment for glioblastoma mulitforme. Plant protein 'doorkeepers' block invading microbes, study finds A group of plant proteins that "shut the door" on bacteria that would otherwise infect the plant's leaves has been identified for the first time by a team of researchers in Denmark, at the University of California, Davis, and at UC Berkeley. MicroRNAs help control HIV life cycle Scientists at Burnham Institute for Medical Research (Burnham) have discovered that specific microRNAs (non-coding RNAs that interfere with gene expression) reduce HIV replication and infectivity in human T-cells. Like burrs on your clothes, molecule-size capsules can deliver drugs by sticking to targeted cells It is now possible to engineer tiny containers the size of a virus to deliver drugs and other materials with almost 100 percent efficiency to targeted cells in the bloodstream. Inflammation markers linked more with fatal than nonfatal cardiovascular events in elderly A study published this week in the open access journal PLoS Medicine shows that for elderly people at risk of cardiovascular disease, the presence of inflammatory markers in the blood can identify that an individual is at a higher risk of a fatal rather than a non-fatal heart attack or stroke. A urine test for appendicitis? Appendicitis is the most common childhood surgical emergency, but the diagnosis can be challenging, especially in children, often leading to either unnecessary surgery in children without appendicitis, or a ruptured appendix and serious complications when the condition is missed. Transplant drug stimulates immune memory Rapamycin, a drug given to transplant recipients to suppress their immune systems, has a paradoxical effect on cells responsible for immune memory, scientists at the Emory Vaccine Center have discovered. Statins can protect against Alzheimer's disease, according to new study High cholesterol levels are considered to be a risk factor not only for cardiovascular disease including stroke, but also for the development of Alzheimer's disease. More Immune Response Current Events and Immune Response News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||